Summary Keywords IBD, GLP-1, GLP-1 receptor agonists, diabetes, obesity Citation Migliorisi G, Gabbiadini R, Dal Buono A, Ferraris M, Privitera G, Petronio L, Bertoli P, Bezzio C and Armuzzi A (2025) GLP-1 receptor agonists in IBD: exploring the crossroads of metabolism and inflammation
Choudhary MM, France TJ, Teknos TN, Kumar P
Supply and availability issues create another switching scenario
Together, factors including the number of peptide varieties (often mixed and matched via stacking), individual genetics, presence of countless medical conditions and disparate personal goals create a huge amount of untested variables and potential outcomes
Glob Adv Health Med
Start your journey today with a qualified medical consultation.